A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
Clinical trial NCT03843359 · TERMINATED
Trial details
- NCT number
- NCT03843359
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2024-04-04
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.